Mouse models of intestinal inflammation and cancer
- 1.5k Downloads
Chronic inflammation is strongly associated with approximately one-fifth of all human cancers. Arising from combinations of factors such as environmental exposures, diet, inherited gene polymorphisms, infections, or from dysfunctions of the immune response, chronic inflammation begins as an attempt of the body to remove injurious stimuli; however, over time, this results in continuous tissue destruction and promotion and maintenance of carcinogenesis. Here, we focus on intestinal inflammation and its associated cancers, a group of diseases on the rise and affecting millions of people worldwide. Intestinal inflammation can be widely grouped into inflammatory bowel diseases (ulcerative colitis and Crohn’s disease) and celiac disease. Long-standing intestinal inflammation is associated with colorectal cancer and small-bowel adenocarcinoma, as well as extraintestinal manifestations, including lymphomas and autoimmune diseases. This article highlights potential mechanisms of pathogenesis in inflammatory bowel diseases and celiac disease, as well as those involved in the progression to associated cancers, most of which have been identified from studies utilizing mouse models of intestinal inflammation. Mouse models of intestinal inflammation can be widely grouped into chemically induced models; genetic models, which make up the bulk of the studied models; adoptive transfer models; and spontaneous models. Studies in these models have lead to the understanding that persistent antigen exposure in the intestinal lumen, in combination with loss of epithelial barrier function, and dysfunction and dysregulation of the innate and adaptive immune responses lead to chronic intestinal inflammation. Transcriptional changes in this environment leading to cell survival, hyperplasia, promotion of angiogenesis, persistent DNA damage, or insufficient repair of DNA damage due to an excess of proinflammatory mediators are then thought to lead to sustained malignant transformation. With regard to extraintestinal manifestations such as lymphoma, however, more suitable models are required to further investigate the complex and heterogeneous mechanisms that may be at play.
KeywordsIntestinal inflammation Intestinal cancer Mouse models
This work was supported in part by NIH Grant ES09519 (RS), the Jonsson Comprehensive Cancer Foundation (RS), a TRP Grant (L618-B11) from the FWF (AS and RS) and a UCLA-NIEHS training grant in Molecular Toxicology (AW).
Compliance with ethical standards
Conflict of interest
The authors declare that there are no conflicts of interest.
- American Cancer Society (2008) Cancer facts and figures 2008. American Cancer Society, AtlantaGoogle Scholar
- Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, Schütz M, Bartsch B, Holtmann M, Becker C (2000) Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat Med 6(5):583–588PubMedCrossRefGoogle Scholar
- Coombes J, Maloy K (2007) Control of intestinal homeostasis by regulatory T cells and dendritic cells. Elsevier, AmsterdamGoogle Scholar
- Cotran RS, Kumar V, Collins T (1999) Robbins pathological basis of disease, 6th edn. WB Saunders, Philadelphia, pp 50–458Google Scholar
- Guldenschuh I, Hurlimann R, Muller A, Ammann R, Mullhaupt B, Dobbie Z, Zala G, Flury R, Seelentag W, Roth J (2001) Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis. Dis Colon Rectum 44:1090–1097PubMedCrossRefGoogle Scholar
- Hecht S (1997) Tobacco and cancer: approaches using carcinogen biomarkers and chemoprevention. Ann N Y Acad Sci 833(1 Cancer: Genetics and the Environment): 91–111Google Scholar
- Hovhannisyan Z, Weiss A, Martin A, Wiesner M, Tollefsen S, Yoshida K, Ciszewski C, Curran SA, Murray JA, David CS, Sollid LM, Koning F, Teyton L, Jabri B (2008) The role of HLA-DQ8 β57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature 456:534–538PubMedPubMedCentralCrossRefGoogle Scholar
- McGhee JR et al (1998) Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66(11):5224–5231Google Scholar
- Neurath MF et al (1996) Effects of IL-12 and antibodies to IL-12 on established granulomatous colitis in mice. Ann N Y Acad Sci 795(Interleukin 12 Cellular and Molecular Immunology of an Important Regulatory Cytokine):368–370Google Scholar
- Okuda Y et al (2003) Development of colitis in signal transducers and activators of transcription 6-deficient T-cell receptor -deficient mice a potential role of signal transducers and activators of transcription 6-independent interleukin-4 signaling for the generation of Th2-biased pathological CD4+ T Cells. Am J Pathol 162(1):263–271PubMedPubMedCentralCrossRefGoogle Scholar
- Shoenfeld Y, Gershwin M (2000) Cancer and autoimmunity. In: Shoenfeld Y, Gershwin M (eds) Cancer and autoimmunity. Elsevier, Amsterdam, pp 1–446Google Scholar
- Stewart BW, Kleihues P (2003) World cancer report. Iarc, Lyon, pp 56–66Google Scholar
- Westbrook A, Schiestl RH (2010) Atm deficient mice exhibit increased sensitivity to dextran sulfate sodium-induced colitis characterized by elevated DNA damage and persistent immune activation damage and persistent immune activation. Cancer Res 70(5):1875–1884. doi: 10.1158/0008-5472.CAN-09-2584 PubMedPubMedCentralCrossRefGoogle Scholar